Table 3. Risk of bisphosphonates on oesophageal and gastric cancer in men.

	Oesophageal Cancer Odds Ratio (95% CI)	Gastric Cancer Odds Ratio (95% I)	All UGI Cancer Odds Ratio (95%CI)
Men taking bisphosphonates	0.87 (0.65–1.18) (54 cases, 246 controls)	0.77 (0.50–.20) (24 cases, 124 controls)	0·84 (0.66–1.07) (78 cases, 370 controls)
Adjusted for smoking	0.78 (0.56–1.09)	0.87 (0.55–1.36)	0.81 (0.62–1.06)
Adjusted for smoking, alcohol intake, PPI, H. pylori, dyspepsia andBMI	0.73 (0.53–1.03)	0.77 (0.49–1.21)	0.75 (0.57–0.98)